BMEA (Biomea Fusion) FFO


BMEA Biomea Fusion Inc BMEA
31 GF Score
Price $1.31
! 1 Warning Sign
View Full Analysis

What is Biomea Fusion FFO?

FFO (Funds from operations) only applies to REITs.

BMEA
31GF Score
Biomea Fusion Inc BMEA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biomea Fusion Business Description

Address 1599 Industrial Road, San Carlos, CA, USA, 94070
Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.
31GF Score

Get the complete analysis for BMEA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.31
Price